These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. Taddei S; Virdis A; Ghiadoni L; Magagna A; Pasini AF; Garbin U; Cominacini L; Salvetti A J Hypertens; 2001 Aug; 19(8):1379-86. PubMed ID: 11518845 [TBL] [Abstract][Full Text] [Related]
11. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. On YK; Kim CH; Oh BH; Lee MM; Park YB Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314 [TBL] [Abstract][Full Text] [Related]
13. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. Agabiti-Rosei E Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883 [TBL] [Abstract][Full Text] [Related]
16. A rationale for treatment of endothelial dysfunction in hypertension. Ruschitzka F; Corti R; Noll G; Lüscher TF J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841 [TBL] [Abstract][Full Text] [Related]
17. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? Ruschitzka FT; Lüscher TF Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622 [TBL] [Abstract][Full Text] [Related]
18. Optimal vascular protection: a case for combination antihypertensive therapy. Vogel RA Prev Cardiol; 2006; 9(1):35-41. PubMed ID: 16407701 [TBL] [Abstract][Full Text] [Related]
19. Advances in pharmacologic modulation of nitric oxide in hypertension. Mizuno Y; Jacob RF; Mason RP Curr Cardiol Rep; 2010 Nov; 12(6):472-80. PubMed ID: 20809234 [TBL] [Abstract][Full Text] [Related]
20. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Ghiadoni L; Virdis A; Magagna A; Taddei S; Salvetti A Hypertension; 2000 Jan; 35(1 Pt 2):501-6. PubMed ID: 10642349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]